Lower Rates of Staphylococcus aureus Bloodstream Infection in Patients on Hemodialysis Receiving Trimethoprim-Sulfamethoxazole Melioidosis Prophylaxis

Aliya Bryce, Sara Davison, Bart J. Currie, Johanna M. Birrell, Robert W. Baird, Asanga Abeyaratne, Sandawana William Majoni, Teana Brewster-O'Brien, Steven Y. C. Tong

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)
31 Downloads (Pure)

Abstract

Hemodialysis is a risk factor for Staphylococcus aureus bloodstream infection (SAB). In this single-center study, SAB rates were 56% lower during the monsoonal wet season when patients on hemodialysis receive supervised melioidosis prophylaxis with trimethoprim-sulfamethoxazole. This intervention may reduce SAB rates in high-risk patients; however, further targeted studies are required.

Original languageEnglish
Article numberofae431
Number of pages4
JournalOpen Forum Infectious Diseases
Volume11
Issue number8
DOIs
Publication statusPublished - Aug 2024

Keywords

  • antibiotic prophylaxis
  • bloodstream infection
  • hemodialysis
  • Staphylococcus aureus
  • trimethoprimsulfamethoxazole

Fingerprint

Dive into the research topics of 'Lower Rates of Staphylococcus aureus Bloodstream Infection in Patients on Hemodialysis Receiving Trimethoprim-Sulfamethoxazole Melioidosis Prophylaxis'. Together they form a unique fingerprint.

Cite this